plasma
Whereas increased cardiac BK-(1-9) levels       may contribute to the reduction of cardiac hypertrophy, the reduction in plasma       Ang-(1-7) levels and increase in Ang II levels in plasma and tissues may       compromise the therapeutic effects of combined NEP/ACE inhibition.
Whereas increased cardiac BK-(1-9) levels       may contribute to the reduction of cardiac hypertrophy, the reduction in plasma       Ang-(1-7) levels and increase in  @OBJECT$  levels  @PREDICAT$   @SUBJECT$  and tissues may       compromise the therapeutic effects of combined NEP/ACE inhibition.